Results 11 to 20 of about 350,390 (302)
Pentoxifylline: An Immunomodulatory Drug for the Treatment of COVID-19
Journal of Pure and Applied Microbiology, 2020 Rapidly spreading outbreak of the novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is causing serious health concerns worldwide.
Hiren A. Dhameliya +4 more
doaj +3 more sources
COVID-19 Drug Treatment in China. [PDF]
Curr Pharmacol Rep, 2020 An unprecedented outbreak of the novel coronavirus in China (COVID-19) occurred in December 2019, and then engulfed the entire world, presenting a significant and urgent threat to global health. Many research institutes have been involved in the development of drugs and vaccines against COVID-19.At present, the strategy of new use of old drugs is ...
Fan L, Jiang S, Yang X, Wang Z, Yang C.
europepmc +4 more sources
COVID-19: Drug Targets and Potential Treatments [PDF]
Journal of Medicinal Chemistry, 2020 Currently, humans are immersed in a pandemic caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which threatens public health worldwide. To date, no drug or vaccine has been approved to treat the severe disease caused by this coronavirus, COVID-19.
Gil, Carmen +10 more
openaire +3 more sources
Drug treatment of COVID-19 infection
Current Opinion in Pulmonary Medicine, 2023 Purpose of review COVID-19 pandemic has caused more than 6.6 million deaths globally. Tremendous efforts have been committed for the development of new and repurposed drugs for the treatment of COVID-19. Although different international and national guidelines share consensus in the management of COVID-19 disease with different
Lui, Grace, Guaraldi, Giovanni
openaire +2 more sources
Drug repurposing for the treatment of COVID-19
Journal of Pharmacological Sciences, 2022 Coronavirus disease 2019 (COVID-19) remains prevalent worldwide since its onset was confirmed in Wuhan, China in 2019. Vaccines against the causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have shown a preventive effect against the onset and severity of COVID-19, and social and economic activities are gradually recovering.
Yuri Kato +7 more
openaire +3 more sources
Drugs for COVID-19 Treatment: A New Challenge
Applied Biochemistry and Biotechnology, 2023 COVID-19 infection is a new disease and our knowledge is limited; day in and day out more and more interesting yet diverse observations are reported by the different research groups from different corners of the world. So, there is an urgent requirement of the invention of some effective and efficient drugs that can carry out the end of the deadly ...
Pratik Talukder +5 more
openaire +2 more sources
Drug eruption: A mimicker of Coronavirus disease-2019 rash
Turkderm Turkish Archives of Dermatology and Venereology, 2022 Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infections can be associated with several cutaneous lesions, among which maculopapular rash is the most common.
Tülin Ergun +6 more
doaj +1 more source
COVID-19 and chronological aging : senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? [PDF]
, 2020 COVID-19, also known as SARS-CoV-2, is a new emerging zoonotic corona virus of the SARS (Severe Acute Respiratory Syndrome) and the MERS (Middle East Respiratory Syndrome) family.
Auwerx +30 more
core +2 more sources
Hepatology Communications, 2023 Background:. Coronavirus disease 2019 (COVID-19) is a global pandemic that has caused more than 600 million cases and over six million deaths worldwide.
Kaiyan Liu +6 more
doaj +1 more source
Repurposing Interleukin-6 Inhibitors to Combat COVID-19. [PDF]
, 2020 Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is a pandemic with major implications across the world. One of the most frequent causes of death from SARS-CoV-2 is fatal pneumonia from coronavirus disease 2019 (COVID-19), which is associated
Kato, Shumei, Kurzrock, Razelle
core +1 more source